Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05534971 · ClinicalTrials.gov registry record · Phase 4
Central Line Study
A Phase 4 study of Shock, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT05534971 is a Phase 4 study of Shock that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 160 participants, below the 464-participant average among 9 other Shock trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05534971, a Phase 4 study of Shock, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
Two different techniques for placing a central venous catheter will be compared. The studyu team hypothesizes that clinicians randomized to the peripheral catheter technique will have higher first attempt success rates, fewer procedural complications, and a shorter mean time to procedure completion than physicians assigned to wire through hollow bore needle.
Conditions Studied
Interventions
- PROCEDURE Central venous catheter insertion
Study Locations (1)
New York
- Montefiore - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2022-11-16 |
| Est. Completion | 2027-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05534971
The ClinicalTrials.gov registry entry for NCT05534971 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 464-participant average among 9 other Shock trials with a reported enrollment target (66% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Shock appearing as the primary indexed condition, and to 1 intervention - of which Central venous catheter insertion is the first listed.
NCT05534971 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05534971 about?
NCT05534971 is a clinical study titled "Central Line Study". Two different techniques for placing a central venous catheter will be compared. The studyu team hypothesizes that clinicians randomized to the peripheral catheter technique will have higher first attempt success rates, fewer procedural complications, and a shorter mean time to procedure completion ...
What is the current status of trial NCT05534971?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 160 participants. The study started on 2022-11-16. Estimated completion is 2027-12.
What conditions does trial NCT05534971 study?
This clinical trial studies the following conditions: Shock.
What interventions are being tested in trial NCT05534971?
The interventions under investigation include: Central venous catheter insertion (PROCEDURE).
Who is sponsoring clinical trial NCT05534971?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05534971 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Shock
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Vasoactive Drugs in Intensive Care Unit
RECRUITING · Phase 4
-
Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock
RECRUITING · Phase 4
-
Effect of Nebulized Bronchodilators on Heart Rate
COMPLETED · Phase 4
-
Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance
RECRUITING
-
Resuscitative TEE Collaborative Registry
RECRUITING
-
Evaluating Fluid Responsiveness in ICU Patients Using VTI and Trendelenburg Positioning
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.